down arrow

Chengdu Olymvax Biopharmaceuticals, Inc.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000051H8
CNY
25.34
0.54 (2.18%)

Dec 19

SHG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
0.00
0.00
0.00
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
924.68
916.91
881.63
844.66
376.97
340.84
Shareholder's Funds
924.68
916.91
881.63
844.66
376.97
340.84
Minority Interest
8.82
13.86
10.22
0.00
0.00
0.00
Long-Term Borrowings
361.15
233.18
129.80
35.00
25.00
5.00
Secured Loans
361.15
233.18
129.80
35.00
25.00
5.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
-15.75
-11.36
-7.00
-4.81
0.00
0.00
Other Long Term Liabilities
3.63
8.35
11.69
6.89
5.33
9.21
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.53
1.21
0.09
1.33
2.84
1.60
Total Non-Current Liabilities
253.16
185.64
41.68
6.89
5.33
9.21
Current Liabilities
Trade Payables
86.29
40.06
75.87
34.28
33.08
13.55
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
0.53
1.21
0.09
1.33
2.84
1.60
Total Current Liabilities
595.59
476.22
525.23
341.66
239.83
138.00
Total Liabilities
1,807.04
1,612.61
1,478.87
1,211.88
641.26
488.04
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
756.31
611.08
514.72
388.89
334.94
271.16
Less: Accumulated Depreciation
183.45
156.32
131.12
107.80
88.40
72.55
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
572.87
454.76
383.60
281.09
246.54
198.61
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
10.70
Total Non-Current Assets
898.90
681.42
542.98
336.91
278.50
238.36
Current Assets Loans & Advances
Current Investments
17.50
0.00
90.00
200.00
10.00
0.00
Inventories
85.68
72.12
78.52
74.50
46.00
33.93
Sundry Debtors
570.35
491.55
491.69
342.52
192.26
114.83
Cash and Bank
224.16
362.07
269.23
254.37
103.98
95.62
Other Current Assets
898.70
926.83
933.23
872.49
353.04
246.24
Short Term Loans and Advances
1.00
1.10
3.78
1.10
0.81
1.86
Total Current Assets
908.14
931.19
935.89
874.98
362.76
249.68
Net Current Assets (Including Current Investments)
312.55
454.97
410.67
533.31
122.93
111.68
Total Current Assets Excluding Current Investments
908.14
931.19
935.89
874.98
362.76
249.68
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
1,807.04
1,612.61
1,478.87
1,211.88
641.26
488.04
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
361.15
233.18
129.80
35.00
25.00
5.00
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Dec 2024 is 40.75% vs 491.16% in Dec 2023

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Dec 2024 is -56.53% vs -28.57% in Dec 2023

stock-summary

Fixed Assets

YoY Growth in year ended Dec 2024 is 25.97% vs 18.55% in Dec 2023

stock-summary

Investments

No Investments in the last few periods;

stock-summary

Current Assets

YoY Growth in year ended Dec 2024 is -2.48% vs -0.50% in Dec 2023

Compare Balance Sheet Results of Chengdu Olymvax Biopharmaceuticals, Inc.
Markets Mojo
Figures in Million
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
924.68
0
924.68
0.00%
Shareholder's Funds
924.68
0
924.68
0.00%
Minority Interest
8.82
0
8.82
0.00%
Long-Term Borrowings
361.15
0
361.15
0.00%
Secured Loans
361.15
0
361.15
0.00%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
-15.75
0
-15.75
0.00%
Other Long Term Liabilities
3.63
0
3.63
0.00%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
0.53
0
0.53
0.00%
Total Non-Current Liabilities
253.16
0
253.16
0.00%
Current Liabilities
Trade Payables
86.29
0
86.29
0.00%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
0.53
0
0.53
0.00%
Total Current Liabilities
595.59
0
595.59
0.00%
Total Liabilities
1,807.04
0
1,807.04
0.00%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
756.31
0
756.31
0.00%
Less: Accumulated Depreciation
183.45
0
183.45
0.00%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
572.87
0
572.87
0.00%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
0
0
0.00
0.00%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
0
0
0.00
0.00%
Total Non-Current Assets
898.90
0
898.90
0.00%
Current Assets Loans & Advances
Current Investments
17.50
0
17.50
0.00%
Inventories
85.68
0
85.68
0.00%
Sundry Debtors
570.35
0
570.35
0.00%
Cash and Bank
224.16
0
224.16
0.00%
Other Current Assets
898.70
0
898.70
0.00%
Short Term Loans and Advances
1.00
0
1.00
0.00%
Total Current Assets
908.14
0
908.14
0.00%
Net Current Assets (Including Current Investments)
312.55
0
312.55
0.00%
Total Current Assets Excluding Current Investments
908.14
0
908.14
0.00%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
1,807.04
0
1,807.04
0.00%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
361.15
0
361.15
0.00%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Borrowings 249.53 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 40.75% vs 491.16% in Dec 2023

Annual - Other Long Term Liabilities
Other Long Term Liabilities 3.63 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -56.53% vs -28.57% in Dec 2023

Annual - Fixed Assets
Fixed Assets 572.87 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 25.97% vs 18.55% in Dec 2023

Annual - Investments
Markets Mojo
No Investments in the last few periods
stock-summary

No Investments in the last few periods;

Annual - Current Assets
Current Assets 908.14 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -2.48% vs -0.50% in Dec 2023

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."